Open AccessA Thrice-Weekly Ertapenem Regimen Is Practical for Hemodialysis Patients
Author(s) -
YuneFang Ueng,
Hong-Jaan Wang,
ShiaoChi Wu,
Yee-Yung Ng
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01427-19
Subject(s) - ertapenem , hemodialysis , medicine , regimen , intensive care medicine , antibiotics , microbiology and biotechnology , imipenem , biology , antibiotic resistance
Change of ertapenem dosage from 500 mg daily to thrice weekly after each hemodialysis session can maintain the plasma concentration above 2 mg/L, and be practical in hemodialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom